908 Devices Inc. reports results for the quarter ended June 30 - Earnings Summary

908 Devices

11/08/2026 14:32

908 Devices Inc. MASS.OQ reported a quarterly adjusted loss of 32 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -18 cents.  The mean expectation of five analysts for the quarter was for a loss of 17 cents per share. Wall Street expected results to range from -19 cents to -15 cents per share.
Revenue rose 23.3% to $16.07 million from a year ago; analysts expected $15.37 million. 
908 Devices Inc.'s reported EPS for the quarter was a loss of 32 cents​.
The company reported a quarterly loss of $11.89 million.
908 Devices Inc. shares had risen by 1.1% this quarter and gained 67.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 5.6% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 5 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is  "buy."
Wall Street's median 12-month price target for 908 Devices Inc. is $11.00, about 20% above its last closing price of $8.80
This summary was machine generated from LSEG data August 11 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.17
-0.32
Missed
Mar. 31 2026 
-0.16
-0.32
Missed
Dec. 31 2025 
-0.07
0.10
Beat
Sep. 30 2025 
-0.17
-0.41
Missed